Suceeding With Innovation Future Technologies in HF #SWIFT-HF Inaugural meeting in NYC! Exciting times ahead, gearing up to bring cutting-edge technology to patients for better healthcare outcomes. The enthusiasm for innovation is palpable! 🌐💡 #research#patientcare#Innovation
🌟 A star is born!
Behind the curtain of dust and gas in these “Cosmic Cliffs” are previously hidden baby stars, now uncovered by Webb. We know — this is a show-stopper. Just take a second to admire the Carina Nebula in all its glory: https://t.co/tlougFWg8B #UnfoldTheUniverse
Today was my last day of advanced HF and transplant fellowship @EmoryMedicine. Very thankful for the opportunity and the mentorship throughout this past year. Will miss the amazing ppl! @KunalBhattMD@amorrismd @annievanb @rcg1812 @MahmoudHAbdou @DrManiCTSurgery
Happy #NationalDonorDay! Share the love & register your decision to be an organ, eye & tissue donor at https://t.co/sX9arWRhfD. Thank you to all donors, registered donors & donor families for your generosity! 💙💚❤️ #DonateLife Learn more at https://t.co/p7YHoxxyRj
Breaking News: A man received a new heart from a genetically modified pig, a medical first that offers hope to hundreds of thousands of patients with failing organs. https://t.co/CMQEPN9IL9
Do you feel comfortable interpreting LVAD pump parameters & applying them to patient care?
Excited to share our review covering the physiology & clinical utility of the HeartMate LVAD pump parameters. Now in-press @JCardFail!
https://t.co/gs5rwOQP0d
via @NYTOpinion a thoughtful piece about the difficult decisions we face re: transplant candidacy. How do we ensure just and fair organ allocation while making sure everyone’s voice is heard? @ISHLT @JeffTeuteberg @YasMoayedi https://t.co/blfjUoX5EJ
Delighted to share our paper on Cardiogenic Shock in #CICU w/ & w/o Shock Teams in @JACCJournals.
1) 1st multicenter Shock Team description
2) Shock Team: ⬇️ CICU mortality, ⬇️ ICU utilization & ⬇️ overall MCS
3) Shock Team: earlier PAC, ⬆️ advanced MCS
https://t.co/0peBwE87FA
GUIDE-HF results presentation by @LindenfeldJoann at @escardio#ESCCongress... expanding #CardioMEMS to NYHA class II and patients with elevated NTproBNP without HF hospitalization... my take-home is that it is a positive trial given pre-COVID-19 impact analysis
RHC for cardiogenic shock remains underutilized despite reducing risk for stroke, death, and readmission for HF. Check out our fresh press. https://t.co/sp9cwsvEhC
Incredible paper @JCardFail - "Hemodynamics for the HF Clinician: A State-of-the-Art Review". Important read for everyone interested in HF by Drs. Hsu, Fang & Borlaug - You'll learn a ton from this!
@HFSA#cardiotwitter@UUtah@hopkinsheart@MayoClinic
https://t.co/2iV6nFQIst